<DOC>
	<DOC>NCT00583154</DOC>
	<brief_summary>To compare the safety and efficacy of BLI-801 administered at 4 dose levels in constipated adults.</brief_summary>
	<brief_title>A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Cathartics</mesh_term>
	<criteria>Male or female subjects at least 18 years of age Constipated according to ROME I criteria Otherwise in good health, as determined by physical exam and medical history If female, and of childbearing potential, is using an acceptable form of birth control (hormonal birth control, IUD, doublebarrier method, depot contraceptive, sterilized, abstinent, or vasectomized spouse) Negative urine pregnancy test at screening, if applicable In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study Subjects with known or suspected ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis, toxic megacolon Subjects taking laxatives or prokinetic agents that refuse to discontinue these treatments for the duration of the study Subjects who are pregnant or lactating, or intending to become pregnant during the study Subjects of childbearing potential who refuse a pregnancy test Subjects who are allergic to any BLI801 component. Subjects who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>constipation</keyword>
	<keyword>laxative</keyword>
</DOC>